AlphAIAlphAI — Financial news for AI agents
prnewswire.comOCT 11 min read$CAH

Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5

Cardinal Health (CAH) will release its fiscal Q1 2027 results on November 5 before the NYSE opening. A webcast discussion will follow at 8:30 a.m. ET. The company is a distributor of pharmaceuticals and medical products. Details will be available on their Investor Relations page.

Original reporting
prnewswire.com
Published Oct 1, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 10:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5 — source image
Source · prnewswire.com
Decision brief

The 30-second read

$CAHNeutralMed
01

Why it matters

The announcement sets the calendar for market participants; traders may adjust positions based on expectations of earnings surprise.

02

Market read

The release date announcement is a modestly material corporate event that may generate short‑term trading interest.

03

What to watch

Potential impact of macro‑economic conditions on Cardinal Health's upcoming earnings has not been discussed.

Relevance 5/10Novelty 5/10Timing: pre‑market on Nov 5

Background

Cardinal Health is a major U.S. distributor of pharmaceuticals and medical products. The company typically releases earnings quarterly, and the timing can influence short‑term stock movement.

Company-level read

Ticker impact

$CAHNeutralHigh confidence
Context

Cardinal Health announced it will release its FY2027 Q1 results on November 5, a new disclosure of the earnings release timing.

Expected impact

potential heightened trading activity with unclear direction until results are posted

Evidence & confidence

Earnings release dates are material for traders; no guidance is given, so the impact is limited to timing‑related positioning.

Market effects

Sector

May affect the healthcare distribution sector as peers watch Cardinal Health's results for market trends.

Regional

U.S. investors will note the release; limited broader regional effect.

Global

Low global relevance beyond U.S. healthcare investors.

Counterpoint

What could challenge this read

Without guidance, the stock could be oversold ahead of the release, presenting a buying opportunity if market overreacts to the announcement.

Key entities

  • Company
    Cardinal Health

    U.S. healthcare distribution and services firm (NYSE: CAH).

Read at source← All news

Related articles

OCT 1
$MCKMed

McKesson (MCK) and Cardinal Health Extend CVS Health Distributio

McKesson (MCK) and Cardinal Health renewed their pharmaceutical distribution agreements with CVS Health, extending contracts through June 2032. Both companies reaffirmed their fiscal 2027 earnings guidance. McKesson's stock is trading at $890.28, 6.8% above its GF Value of $833.49, with a GF Score of 86/100. Insider sales totaled $28.3 million over the past year, while 15 premium gurus hold MCK with a net positive addition.

gurufocus.com2 min
OCT 1
$CAHMed

Why Is Cardinal Health and McKesson Stock Trading Higher Today - CVS Health (NYSE:CVS), McKesson (NYSE:MC

Cardinal Health (CAH) and McKesson (MCK) extended their distribution agreements with CVS Health (CVS) until 2032. Cardinal Health reaffirmed its 2027 adjusted earnings guidance of $12.40-$12.60 per share, while McKesson reiterated its 2027 outlook of $44.20-$45 per share. Both companies' stocks rose on the news, with McKesson up 4.28% and Cardinal Health up 2.94%.

benzinga.com2 min
OCT 1
$CAHMed

Cardinal Health (CAH) Extends CVS Distribution Deal Through 2032

Cardinal Health (CAH) extended its pharmaceutical distribution agreements with CVS Health through June 2032. The company reaffirmed its fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60 and long-term growth range of 12% to 14%. The deal secures a key partnership and provides revenue visibility, though investors should note non-GAAP exclusions and industry pressures.

gurufocus.com2 min
OCT 1
$CAHMed

Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

CARDINAL HEALTH INC (CAH) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health DUBLIN, Ohio, October 1, 2026 – Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existin

SEC EDGAR 8-K1 min